PubRank

T M Phillips

Author PubWeight™ 79.42‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Tumour-specific antibodies in human malignant melanoma and their relationship to the extent of the disease. Br Med J 1969 3.37
2 Autoimmunization with irradiated tumour cells in human malignant melanoma. Br Med J 1970 2.91
3 Immunological studies in nephrotic syndrome associated with extrarenal malignant disease. Lancet 1971 2.22
4 Brief report: idiotypic IgA nephropathy in patients with human immunodeficiency virus infection. N Engl J Med 1992 1.90
5 Neuropeptides and neurotrophins in neonatal blood of children with autism or mental retardation. Ann Neurol 2001 1.87
6 Immunologic function and survival in hemodialysis patients. Kidney Int 1998 1.82
7 Neonatal cytokines and coagulation factors in children with cerebral palsy. Ann Neurol 1998 1.80
8 The specificity of surface membrane immunofluorescence in human malignant melanoma. Int J Cancer 1972 1.75
9 Circulating immune complexes in schistosomiasis due to Schistosoma mansoni. Br Med J 1975 1.51
10 Presence of anti-pituitary hormone antibodies in patients with empty sella syndrome and pituitary tumours. Clin Endocrinol (Oxf) 1993 1.49
11 Magnesium-deficiency elevates circulating levels of inflammatory cytokines and endothelin. Mol Cell Biochem 1992 1.18
12 Epstein-Barr virus shedding by astronauts during space flight. Brain Behav Immun 2005 1.16
13 Herpes simplex type 2 encephalitis concurrent with known cerebral metastases. Acta Neuropathol 1979 1.13
14 Target role of Langerhans cells in mycosis fungoides: transmission and immuno-electron microscopic studies. J Cutan Pathol 1979 1.10
15 Dyadic relationship conflict, gender, and mortality in urban hemodialysis patients. J Am Soc Nephrol 2000 1.03
16 Mediators of fetal inflammation in extremely low gestational age newborns. Cytokine 2001 1.02
17 Pathobiology of magnesium deficiency: a cytokine/neurogenic inflammation hypothesis. Am J Physiol 1992 1.02
18 Immunoregulation by neuropeptides in magnesium deficiency: ex vivo effect of enhanced substance P production on circulating T lymphocytes from magnesium-deficient mice. Magnes Res 1996 0.99
19 Blockade of cardiac inflammation in Mg2+ deficiency by substance P receptor inhibition. Circ Res 1994 0.98
20 Microvascular assessment of burn depth conversion during varying resuscitation conditions. J Burn Care Rehabil 2001 0.97
21 HIV-associated immune-mediated renal disease. Kidney Int 1993 0.97
22 Carcinoma-associated hemolytic-uremic syndrome: a complication of mitomycin C chemotherapy. J Clin Oncol 1985 0.95
23 Stereoselective reduction of pyruvate by sodium borohydride catalyzed by pyruvate kinase. Biochim Biophys Acta 1973 0.95
24 Immunological associations of the halo naevus with cutaneous malignant melanoma. Br J Dermatol 1973 0.94
25 Neurogenic peptides and the cardiomyopathy of magnesium-deficiency: effects of substance P-receptor inhibition. Mol Cell Biochem 1994 0.94
26 A system of immunofluorescence in the study of tumour cells. Rev Eur Etud Clin Biol 1970 0.93
27 Unilateral megalencephaly, cerebral cortical dysplasia, neuronal hypertrophy, and heterotopia: cytomorphometric, fluorometric cytochemical, and biochemical analyses. Acta Neuropathol 1979 0.93
28 Persistent cutaneous insulin allergy resulting from high-molecular-weight insulin aggregates. Diabetes 1990 0.92
29 Possible explanation for loss of detectable antibody in patients with disseminated malignant melanoma. Nature 1971 0.92
30 The 2003 Carl A Moyer Award: real-time metabolic monitors, ischemia-reperfusion, titration endpoints, and ultraprecise burn resuscitation. J Burn Care Rehabil 2004 0.91
31 Separation of two distinct tumor-associated antibodies in the serum of melanoma patients. J Natl Cancer Inst 1972 0.91
32 Update on topical cyclosporin A. Background, immunology, and pharmacology. Cornea 1990 0.90
33 Ia antigens on indeterminate cells of the epidermis: immunoelectronmicroscopic studies of surface antigens. Br J Dermatol 1979 0.90
34 Magnesium-deficiency-enhanced post-ischemic myocardial injury is reduced by substance P receptor blockade. J Mol Cell Cardiol 1997 0.89
35 Effect of renal replacement therapy on cellular cytokine production in patients with renal disease. Kidney Int 1990 0.88
36 Characterization of the fertilization antigen 1 for the development of a contraceptive vaccine. Proc Natl Acad Sci U S A 1986 0.88
37 Immune complex arthritis in a patient with Schistosoma mansoni infection. Arthritis Rheum 1986 0.88
38 Immune complexes in human melanoma: a consequence of deranged immune regulation. Scand J Immunol 1976 0.88
39 Activation of the neutrophil and loss of plasma glutathione during Mg-deficiency--modulation by nitric oxide synthase inhibition. Mol Cell Biochem 1997 0.86
40 Inverse correlation between age related abnormalities of T-cell immunity and circulating thymosin alpha 1 levels in haemophilia A. Br J Haematol 1984 0.84
41 Response of interleukin-1beta in the magnocellular system to salt-loading. J Neuroendocrinol 2006 0.84
42 VIP and D-ala-peptide T-amide release chemokines which prevent HIV-1 GP120-induced neuronal death. Brain Res 1999 0.83
43 Regional variation in the levels of transferrin in the CNS of normal and myelin-deficient rats. J Neurochem 1987 0.82
44 Cytokines, neuropeptides, and reperfusion injury during magnesium deficiency. Ann N Y Acad Sci 1994 0.82
45 Interferons and cerebral palsy. J Pediatr 1999 0.82
46 Tumor-associated antigens in human malignant melanoma. Yale J Biol Med 1973 0.82
47 Thymic functions in uremic rats: evidence for thymosin alpha 1 deficiency. Nephron 1985 0.82
48 Cu/Zn superoxide dismutase free radicals, and motoneuron disease. Lancet 1993 0.81
49 Sperm antibodies in vasectomized men and their effects on fertilization. Biol Reprod 1989 0.81
50 Identity of neurotrophic molecules released from astroglia by vasoactive intestinal peptide. Ann N Y Acad Sci 1997 0.81
51 A method for elution of immunoglobulin from the surface of living cells. Rev Eur Etud Clin Biol 1971 0.81
52 Regression of canine mammary carcinoma after immunoadsorption therapy. Cancer Res 1982 0.80
53 Acute myelomonocytic leukemia associated with nephrotic syndrome. A case report with immunological studies. Nephron 1983 0.80
54 Cholinergic mechanisms of cutaneous active vasodilation during heat stress in cystic fibrosis. J Appl Physiol (1985) 2007 0.79
55 The effects of intravenous phytohaemagglutinin in a patient with disseminated malignant melanoma: a clinical and immunological study. Rev Eur Etud Clin Biol 1971 0.79
56 Primary Mycobacterium avium complex infections correlate with lowered cellular immune reactivity in Matschie's tree kangaroos (Dendrolagus matschiei). J Infect Dis 1998 0.79
57 Interleukin-1beta release in the supraoptic nucleus area during osmotic stimulation requires neural function. J Neuroendocrinol 2008 0.79
58 Antigen--antibody complexes related to the baboon endogenous virus in humans with acute lymphoblastic leukemia--hand mirror variant (ALL-HMC). Blood 1980 0.79
59 Vasoactive intestinal peptide. Link between electrical activity and glia-mediated neurotrophism. Ann N Y Acad Sci 1999 0.78
60 Membranoproliferative glomerulonephritis in a patient treated with interferon-alpha for human immunodeficiency virus infection. Am J Kidney Dis 1994 0.78
61 Chemokines released from astroglia by vasoactive intestinal peptide. Mechanism of neuroprotection from HIV envelope protein toxicity. Ann N Y Acad Sci 2000 0.78
62 Zinc modulates mononuclear cellular calcitriol metabolism in peritoneal dialysis patients. Kidney Int 1996 0.78
63 Novel membrane target proteins for lipoxygenase-derived mono(S)hydroxy fatty acids. Biochim Biophys Acta 1999 0.77
64 Eosinophilia and cellular cytokine responsiveness in hemodialysis patients. J Am Soc Nephrol 1992 0.77
65 Vasoactive intestinal peptide releases interleukin-1 from astrocytes. Ann N Y Acad Sci 1996 0.76
66 Acute lymphoblastic leukemia--hand mirror variant--viral immune interrelationship as demonstrated by ultrastructural studies. Am J Hematol 1981 0.76
67 The effect of muscle flap transposition to the fracture site on TNFalpha levels during fracture healing. Plast Reconstr Surg 2000 0.76
68 Plasma homocysteine in women taking hormone replacement therapy: the Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial. J Womens Health Gend Based Med 1999 0.76
69 Zinc balance in combined zinc deficiency and uremia. Kidney Int 1988 0.76
70 Protein A-coated glass beads. Universal support medium for high-performance immunoaffinity chromatography. J Chromatogr 1985 0.76
71 Regulation of stimulated cyclic AMP synthesis by urocanic acid. Photochem Photobiol 1998 0.76
72 Concomitant erythrasma and dermatophytosis of the groin. Br J Dermatol 1979 0.76
73 Use of avidin-coated glass beads as a support for high-performance immunoaffinity chromatography. J Chromatogr 1988 0.76
74 The detection of anti-cholinesterase antibodies in myasthenia gravis. Ann N Y Acad Sci 1981 0.76
75 Treatment of cancer-associated hemolytic uremic syndrome with staphylococcal protein A immunoperfusion. J Clin Oncol 1986 0.76
76 Recombinant leukocyte A interferon in B-cell chronic lymphocytic leukemia: in vivo effects on autologous antitumor immunity. J Biol Response Mod 1985 0.75
77 Inhibition of tumor necrosis factor-alpha by thalidomide in magnesium deficiency. Mol Cell Biochem 1993 0.75
78 Isolation and quantitation of serum IgE levels by high-performance immunoaffinity chromatography. J Chromatogr 1985 0.75
79 Editorial response to author review in publishing science. J Chromatogr B Analyt Technol Biomed Life Sci 2005 0.75
80 Gastric carcinoma and thrombotic thrombocytopenic purpura: association with plasma immune complex concentrations. Br Med J (Clin Res Ed) 1982 0.75
81 Cellular localization of immunoglobulin within human maglignant melanomata. Br J Cancer 1976 0.75
82 Studies of immunological parameters in minimal change nephrotic syndrome. Ann Allergy 1981 0.75
83 Immunological approach to cancer therapy. Lancet 1971 0.75
84 Migraine headaches, migraine equivalents and anti-smooth muscle antibodies. Headache 1988 0.75
85 [The influence of humoral immune mechanisms on metastasizing tumors in humans (author's transl)]. MMW Munch Med Wochenschr 1977 0.75
86 Clinical experiences with extracorporeal immunoperfusion of plasma from cancer patients. J Biol Response Mod 1984 0.75
87 Anti-myelin basic protein antibody in experimental allergic optic neuritis and encephalomyelitis. Ophthalmic Res 1985 0.75
88 Proceedings: Preliminary observations on countercurrent immuno-electrophoresis of Trypanosoma cruzi and Leishmania. Trans R Soc Trop Med Hyg 1975 0.75
89 Summary of a recent workshop/conference report on validation and implementation of bioanalytical methods: implications on manuscript review in the Journal of Chromatography B. J Chromatogr B Analyt Technol Biomed Life Sci 2007 0.75
90 Gonadotropins enhance HLA-DR antigen expression in human granulosa cells. Am J Obstet Gynecol 1992 0.75
91 Expression of ia antigens by murine keratinizing epithelial langerhans cells. Immunogenetics 1978 0.75
92 Specificity of tumor-associated antibodies in sera of patients with uveal melanoma. Can J Ophthalmol 1978 0.75
93 Proceedings: Serological tests for schistosomiasis with a purified egg antigen. Trans R Soc Trop Med Hyg 1974 0.75
94 Biocompatibility of hemodialysis membranes: interrelations between plasma complement and cytokine levels. Blood Purif 2001 0.75
95 Isolation of a specific membrane protein by immunoaffinity chromatography with biotinylated antibodies immobilized on avidin-coated glass beads. J Chromatogr 1989 0.75
96 Immunising against receptors for antigen. Lancet 1976 0.75
97 Biochemical classification of circulating immune complexes in human malignant melanoma and hematologic neoplasms. Oncology 1989 0.75
98 Immune reactions in patients with bladder and prostatic cancer. Aust N Z J Surg 1978 0.75
99 Temporal synthesis and presentation of antigens by cultured B16 melanoma cells. Pigment Cell Res 1987 0.75
100 Hand-mirror cells in acute lymphoblastic leukemia. Am J Clin Pathol 1981 0.75
101 Immunoaffinity isolation of the Lewis blood group antigens. J Chromatogr 1988 0.75
102 Antisperm antibodies in human immunodeficiency virus infection: effects on fertilization and embryonic development. Biol Reprod 1990 0.75
103 [Replication of immune RNA by human lymphoblastoid cells]. C R Acad Sci Hebd Seances Acad Sci D 1977 0.75
104 The value of human T-lymphotropic III screening at the time of cross-match. Transplant Proc 1987 0.75
105 Accelerated recovery from immune-mediated thrombocytopenia with plasmapheresis. Am J Med 1985 0.75
106 Immune derangement in patients with malignant melanoma. J Cutan Pathol 1979 0.75
107 Proceedings: The isolation of specific antigens by affinity chromatography. Trans R Soc Trop Med Hyg 1975 0.75
108 Circulating immune complexes in malignant melanoma: serial studies in 130 patients. Oncology 1986 0.75
109 High-performance affinity chromatography: a rapid technique for the isolation and quantitation of IgG from cerebral spinal fluid. J Chromatogr 1984 0.75
110 Circulating immune complexes after DTP immunization. J Pediatr 1988 0.75
111 Autoantibodies in minimal change nephrotic syndrome. Int J Pediatr Nephrol 1984 0.75
112 Studies with Brugia pahangi 10. An attempt to demonstrate the sharing of antigenic determinants between the worm and its hosts. J Helminthol 1975 0.75
113 A defect in the formation of uropod-bearing lymphocytes (hand-mirror cells) in patients with the Wiskott-Aldrich syndrome. Am J Hematol 1981 0.75
114 Acute myeloid leukemia with hand-mirror cells. Arch Pathol Lab Med 1982 0.75
115 The pathophysiology of circulating immune complexes: their role in host-tumor interactions and removal by immunoadsorption therapy. Contemp Top Immunobiol 1985 0.75
116 Blood-brain and blood-cerebrospinal fluid alterations following neural transplantation. Prog Brain Res 1988 0.75
117 The role of altered vascular permeability in recurrent uveitis. Int Ophthalmol 1981 0.75
118 Modulation of cytokines and myocardial lesions by vitamin E and chloroquine in a Mg-deficient rat model. Am J Physiol 1993 0.75
119 Immune complexes in transitional cell carcinoma. J Urol 1980 0.75
120 Adenosine nucleotide utilization in subtotally nephrectomized rabbits. Clin Physiol Biochem 1989 0.75
121 Ocular features of Kawasaki's disease. Arch Ophthalmol 1982 0.75
122 Serial studies of free radical and antioxidant activity in motor neurone disease and the effect of selegiline. Neurodegeneration 1995 0.75